Specialist-led weight care is here.Check eligibility
Zelta
All articles
Research summary11 min read

Semaglutide injection uses in Hindi: ye kya hai, India mein kis liye di jaati hai, dose aur side effects

Semaglutide injection kya hai, India mein kis liye approved hai, dose kaise badhti hai, side effects aur kab turant doctor se milein. Sirf prescription.

Facts checked on 2 November 2026.

Semaglutide injection ek GLP-1 dawa hai, jo India mein chronic weight management aur type 2 diabetes ke liye approved hai1,2,3. Weight management ke liye iske brands Wegovy aur Poviztra hain, aur type 2 diabetes ke liye Ozempic aur Extensior2,3,4,5. Aasaan shabdon mein, semaglutide body ke natural hormone GLP-1 ke receptor ko chalu karta hai1. PharmEasy ke mutabik India mein iska har brand Schedule H dawa hai, yaani sirf prescription par milta hai3.

India mein semaglutide injection ke kuch brands, CDSCO minutes, company filings aur news reports se. Ye list poori nahi hai: Pharmarack ne April 2026 tak 25 generic brands gine6. Baaki brands semaglutide in India page par hain.

Facts checked on 2 November 2026.

Brand Company Form aur strengths India mein bataya gaya use (source) India mein kab se
Wegovy Novo Nordisk Pen: 0.25, 0.5, 1.0, 1.7, 2.4 mg Chronic weight management (CDSCO minutes) Approval 20 April 2022; launch 24 June 20252,7
Ozempic Novo Nordisk Pen: 0.25, 0.5, 1 mg Type 2 diabetes (Novo Nordisk India) 12 December 20258,9
Poviztra Emcure (Wegovy ka doosra brand) Pen: 0.25, 0.5, 1.0, 1.7, 2.4 mg Chronic weight management (Emcure) 22 December 20254
Extensior Abbott (Ozempic ka doosra brand) FlexTouch pen: 0.25, 0.5, 1 mg Type 2 diabetes (Abbott ki filing) February 2026 mein announce; launch hamare sources mein nahi5
Noveltreat Sun Pharma Pen: 0.25, 0.5, 1, 1.7, 2.4 mg Chronic weight management (Sun) March 202610,11
Obeda injection Dr Reddy's Pen: 2 mg, 4 mg; har pen se kam se kam 4 weekly doses (Dr Reddy's) Type 2 diabetes (Dr Reddy's) March 2026; July 2026 mein supply ruki (Reuters)11,12,13

How this page was checked. Is page ke liye untaalis sources padhe gaye: India se CDSCO minutes, sarkari releases, company filings, news aur PharmEasy; US ke labels aur NCI cancer dictionary; UK ke NHS pages; aur global trials. Saare facts 2 November 2026 ko check kiye gaye. Zelta ke kisi doctor ne abhi tak is page ko review nahi kiya hai.

Semaglutide ka matlab kya hai: India mein bikne wali GLP-1 dawa

Semaglutide ek GLP-1 receptor agonist hai: ye GLP-1 ke receptor se judkar use chalu karta hai1. US label ke mutabik GLP-1 bhookh aur calorie intake ko control karta hai, aur iska receptor dimaag ke bhookh wale hisson mein hai1.

India mein semaglutide injection aur tablet, dono roop mein milta hai. Tablet Rybelsus 3, 7 aur 14 mg strips mein, type 2 diabetes ke liye bikta hai; iske liye semaglutide tablets uses in hindi padhein14. India mein semaglutide ka patent 20 March 2026 ko khatam hua, aur usi weekend generic brands aaye15.

Semaglutide injection kis liye di jaati hai: India ki approvals

CDSCO ke record mein Wegovy 20 April 2022 se adults mein chronic weight management ke liye approved hai2. Emcure ke mutabik Poviztra un adults ke liye hai jinka BMI 30 ya zyada ho, ya 27 ya zyada ho aur wajan se judi koi bimari bhi ho4. Ye use kam calorie wali diet aur zyada physical activity ke saath hai4. Sun Pharma ka Noveltreat bhi isi shart ke saath chronic weight management ke liye hai10.

Ozempic India mein sirf type 2 diabetes ke liye approved hai; 2.4 mg ki dose Wegovy ke liye rakhi gayi hai3,9. Extensior type 2 diabetes wale adults ke liye, diet aur exercise ke saath hai5. January 2026 mein CDSCO ki committee ne MSN aur Natco ke generic injections recommend kiye16. Ye un adults ke liye hain jinki type 2 diabetes theek se control nahi hai, weight management ke liye nahi16. Alag dawa tirzepatide ke liye Mounjaro injection kya hai padhein.

Dose kaise badhti hai: US label ka schedule aur Indian pens

US Wegovy label mein weight loss ka injection 0.25 mg hafte mein ek baar se shuru hota hai, pehle 4 hafte1. Phir har 4 hafte baad dose 0.5 mg, 1 mg aur 1.7 mg hoti hai1. Week 17 se maintenance dose hai: label 2.4 mg recommend karta hai, ya 1.7 mg1. Ye label ka general schedule hai, kisi ek vyakti ka plan nahi.

Dose dheere isliye badhti hai taaki pet ke side effects ka risk kam ho1. US label ke mutabik, agar koi step bardaasht na ho, to doctor agla step 4 hafte rok sakta hai1. India mein Wegovy, Poviztra aur Noveltreat ke pen in paanchon strengths mein hain2,10,17. PharmEasy ke mutabik Wegovy ki har Indian strength schedule ka ek step hai18.

Type 2 diabetes ke liye US Ozempic label mein dose 0.25 mg se shuru hoti hai, aur 4 hafte baad 0.5 mg hoti hai19. Blood sugar ko aur control chahiye ho, to 0.5 mg par kam se kam 4 hafte baad dose 1 mg hoti hai19. Aur control chahiye ho, to 1 mg par kam se kam 4 hafte baad 2 mg19. India mein Ozempic pen 0.25, 0.5 aur 1 mg strengths mein bikta hai9.

Dr Reddy's ke mutabik Obeda injection 2 mg aur 4 mg strengths ke pen mein hai, aur har pen se kam se kam 4 weekly doses milti hain12. Ek dose kitni hai, ye hamare sources mein nahi hai; aapki weekly dose doctor tay karta hai.

US label ke mutabik ek dose chhoot jaaye, to agli dose 2 din se zyada door hone par chhooti dose jaldi lagti hai, warna skip hoti hai1. Lagataar 2 ya zyada doses chhootein, to step-up kam dose se dobara shuru hota hai1. Aisa ho to apne doctor se poochhein. Har step ki table semaglutide dose schedule page par hai.

Injection kaise lagta hai: pen ke basic steps

Ye points US Wegovy label se hain; India mein aapke pack ka leaflet aur doctor ki training hi niyam hai.

  • Label ke mutabik pen ko healthcare provider ki training ke bina use nahi karna chahiye1.
  • Injection skin ke neeche pet, jaangh ya upper arm mein lagta hai, aur har dose par jagah badli jaati hai1.
  • Pet mein injection naabhi (belly button) se 2 inch (5 cm) door lagta hai1.
  • Har injection ke liye nayi needle lagti hai1. Needle ke dono caps hatane hote hain, warna dawa andar nahi jaati1.

PharmEasy ke mutabik Wegovy pen pehli baar use se pehle fridge mein 2–8 °C par rakha jaata hai, freeze nahi20. PharmEasy kehta hai: jo pen freeze hua ho, garam car ya seedhi dhoop mein raha ho, use kabhi use na karein20. US label pehle use ke baad pen ko 56 din tak 15–30 °C par ya fridge mein rakhne deta hai1. Poore steps how to use semaglutide pen par hain.

Side effects, aur kab 112 par call karein ya turant doctor se milein

US label ke weight loss trials mein semaglutide 2.4 mg par nausea 44 % logon ko hua, placebo (dummy injection) par 16 % ko1. Dast 30 % ko hua (placebo par 16 %), aur ulti 24 % ko (placebo par 6 %)1. Kabz 24 % ko hui (placebo par 11 %), aur pet dard 20 % ko (placebo par 10 %)1. Ye rates sirf 2.4 mg weight loss trials ke hain1.

Trials ke combined analysis mein lagbhag sabhi pet ke side effects mild se moderate the, aur zyadatar dose badhne ke dauraan ya thodi der baad aaye21. Phir bhi 4.3 % logon ne inki wajah se treatment band kiya21. Poori list semaglutide side effects guide par hai.

Turant 112 par call karein (India ka emergency number)22:

  • Serious allergic reaction: gala ya jeebh suj jaana, uthe hue khujli wale daane, ya saans lene mein dikkat23.
  • Koi vyakti jiska blood sugar bahut kam ho sakta hai aur jo normal jawab nahi de raha, ya behosh hai24. Behosh vyakti ko kuch khane ya peene ko na dein24.

Turant doctor se sampark karein ya turant medical madad lein:

  • Pet mein bahut tez dard jo theek na ho, chahe ulti ho ya na ho; ye dard peeth tak bhi ja sakta hai. US Medication Guide ke mutabik aise mein dawa rokein aur turant doctor ko phone karein1. NHS ke ek leaflet ke mutabik ye pancreas ki soojan ka sign ho sakta hai25.
  • Achanak nazar chali jaana, aksar ek aankh mein23.
  • Upper pet mein dard, peeli skin ya aankhein, bukhaar, ya clay-coloured stool: ye gallbladder ki problem ke sign ho sakte hain1.
  • Aapko pet ya aant block lage, ya severe kabz ho1,26.

Turant ilaaj karein, phir doctor ko batayein: diabetes wale vyakti mein pasina, kaanpna, dil tez dhadakna ya chakkar low blood sugar ho sakta hai23. NHS jaldi blood sugar badhane wali cheez ki salah deta hai, jaise chhota glass fruit juice24. US label ke mutabik insulin ya sulfonylurea ke saath ye risk badh sakta hai1.

Usi din doctor se sampark karein agar ulti itni ho ki paani andar na tike, ya dast mein khoon ho27. Diabetic eye disease mein nazar badle, tab bhi usi din sampark karein23.

Doctor ko batayein agar gardan mein gaanth, nigalne mein dikkat, saans phoolna, ya aawaz baithi rahe1. Operation ya dental procedure mein general anaesthetic ya sedative se pehle doctor ko batayein ki aap semaglutide lete hain23. Koi bhi side effect aap PvPI helpline 1800 180 3024 par working days mein report kar sakte hain28,29.

Kaun semaglutide injection na le: US label aur NHS ki list

Ye limits US label aur NHS se hain. Apne brand ka leaflet bhi dekhein, aur jo row aap par laagu ho, wo doctor ko pehle batayein.

Kaun semaglutide na le, ya pehle doctor se baat kare1,23.

Facts checked on 2 November 2026.

Kaun Source kya kehta hai Source
Khud ko ya parivaar mein medullary thyroid cancer (MTC), ya MEN 2 Use nahi karna hai US label1
Semaglutide ya uske ingredient se serious allergic reaction Use nahi karna hai US label1
Pregnancy Use nahi hota; doctor ko batayein NHS (UK)23
Pregnancy plan kar rahe hain Pregnancy plan se kam se kam 2 mahine pehle band; doctor se baat karein US label1
Breastfeeding Use nahi hota; dawa doodh mein jaati hai NHS (UK)23
Kisi GLP-1 dawa se allergy, ya pancreatitis abhi ya pehle Suitable na ho sakti hai NHS (UK)23
Severe gastroparesis (pet bahut dheere khaali hota hai) Recommend nahi US label1
Koi dusri semaglutide ya GLP-1 dawa saath mein Recommend nahi US label1

Chuhon jaise jaanwaron (rodents) mein semaglutide ne thyroid C-cell tumours kiye; insaanon mein aisa hota hai ya nahi, ye pata nahi1. MTC inhi C cells ka cancer hai30.

India mein keemat: tareekh aur source ke saath

Novo Nordisk ne 1 April 2026 se India mein daam ghataye; saari strengths ka average lagbhag 24 % Ozempic par aur 27 % Wegovy par tha31,32.

Keematein jaise reported hui, di gayi tareekh par32,33. Ye koi offer nahi hai, aur keematein badalti hain. Extensior ki keemat hamare sources mein nahi hai.

Facts checked on 2 November 2026.

Brand Reported keemat Unit Tareekh aur source
Wegovy ₹1,415 (0.25 mg, taxes ke saath) se ₹4,100 (2.4 mg); 2.4 mg ka daam nahi badla Hafta Novo Nordisk India, 1 April 2026 se32,34
Ozempic ₹1,415 (0.25 mg) se ₹2,275 (1 mg), taxes ke saath Hafta Novo Nordisk India, 1 April 2026 se32,34
Poviztra ₹3,999 (0.25 mg) se ₹8,999 (2.4 mg), MRP Mahina (4 weekly doses) Emcure, 3 April 2026 se35
Generic semaglutide, maker ke hisaab se ₹2,000 se ₹3,500 Mahina MDRF review, The South First, 24 September 202633

Aksar puchhe jaane wale sawal (FAQ)

Semaglutide injection kya hai aur iska upyog kis liye kiya jata hai? Ye ek GLP-1 dawa hai, jo India mein chronic weight management aur type 2 diabetes ke liye di jaati hai1,2,3.

Semaglutide injection ki keemat kya hai? Wegovy aur Ozempic ki 0.25 mg dose 1 April 2026 se ₹1,415 prati hafta hai, taxes ke saath32.

Semaglutide ke kya side effects hain? Sabse aam side effects pet se jude hain: nausea, dast, ulti, kabz aur pet dard1. NHS kehta hai ki serious side effects ho sakte hain, lekin zyadatar kam hi hote hain23.

Kya semaglutide wajan ghatane mein madad karta hai? STEP 1 trial mein semaglutide 2.4 mg par average wajan placebo se zyada ghata, lekin har vyakti ka result alag hota hai36. STEP 1 trial mein adults ne 68 hafte semaglutide 2.4 mg ya placebo liya, dono ke saath lifestyle programme tha36. Average body weight semaglutide par −14.9 % badla, placebo par −2.4 %36. Dawa aur programme band karne ke ek saal baad, ghata hua wajan average do-tihaai wapas aaya37.

Kya semaglutide injection bina doctor ke le sakte hain? Nahi: PharmEasy ke mutabik India mein semaglutide ka har brand Schedule H prescription dawa hai3. March 2026 ki ek report ke mutabik sarkar ne warning di ki generic semaglutide sirf registered medical practitioner ke prescription par bik sakta hai38. Health ministry ki 24 March 2026 ki release ke mutabik GLP-1 weight-loss dawaon ki approval ek shart par hai39. Shart ye hai ki endocrinologists aur internal medicine specialists prescribe karein, aur kuch uses ke liye sirf cardiologists39. Ye do sources alag baat kehte hain, aur ye page fark tay nahi karta. Sarkar ki ek backgrounder salah deti hai ki use se pehle qualified specialist se milein, aur ye dawa sirf prescription par, legitimate aur regulated channels se lein26. Agar aap jaanna chahte hain ki semaglutide aapke liye theek hai ya nahi, to Zelta ke doctor se consultation lein.

Sources

  1. Wegovy US label (DailyMed, 2026-06-18)
  2. CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-04-23
  3. PharmEasy, updated 2026-10-01 (pharmacy listing)
  4. Emcure Pharmaceuticals NSE filing with press release 'Emcure Expands Weight Management Therapy Access with Launch of Poviztra', 2025-12-22
  5. Abbott India BSE filing, 2026-02-27
  6. The South First, 2026-05-11 and 2026-09-24
  7. Business Today, 2025-06-24
  8. The South First, 2025-12-12
  9. Storyboard18, 2025-12-15 (Novo Nordisk India MD to CNBC-TV18)
  10. Sun Pharma press release, 2026-03-21
  11. ThePrint 2026-03-21; Outlook Business 2026-03-20; Torrent NSE filing 2026-03-21
  12. BioSpectrum India, 2026-03-21
  13. Business Standard (Reuters, Rishika Sadam), 'Dr Reddy's launches new generic Ozempic brands amid Obeda supply disruption', 2026-10-23
  14. PharmEasy, updated 2026-10-01 (pharmacy listing)
  15. CareEdge, 2026-03-10
  16. CDSCO SEC (Endocrinology & Metabolism) minutes, 2026-01-06
  17. Indian Pharma Post, 'Emcure Pharma launches weight loss drug Poviztra in India', 2025-12-22
  18. PharmEasy, updated 2026-10-01 (pharmacy listing)
  19. Ozempic US label (DailyMed, 2026-06-01)
  20. PharmEasy, 'Wegovy: Uses, Dosage and Side Effects' (read 2026-10-21) (pharmacy listing)
  21. Wharton et al., 'Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity', Diabetes Obes Metab (2022; online 2021-10-04), pooled STEP 1-3 analysis, PubMed abstract, PMID 34514682; several authors are Novo Nordisk employees
  22. Government of Meghalaya, DIPR press release, 2026-05-27
  23. NHS medicines guide: semaglutide
  24. NHS, 'Low blood sugar (hypoglycaemia)' (read 2026-10-21)
  25. Leeds Community Healthcare NHS Trust, diabetes patient leaflet 'GLP-1 or GIP diabetes treatment' (page dated 2026-04-30)
  26. PIB backgrounder 'GLP-1 Drugs: Use, Risks, and Regulation', 2026-04-01
  27. NHS, 'Diarrhoea and vomiting' (page last reviewed 2023-12-21)
  28. Indian Pharmacopoeia Commission, PvPI page (undated, read 2026-10-21)
  29. Indian Pharmacopoeia Commission, PvPI FAQ (undated, read 2026-10-21)
  30. NCI Dictionary of Cancer Terms: medullary thyroid cancer (undated, read 2026-10-21)
  31. Storyboard18, 2026-04-01
  32. BioSpectrum India, 2026-03-31
  33. The South First (MDRF review in Diabetes Care), 2026-09-24
  34. Indian Pharma Post (Novo Nordisk India price table), 2026-03-31
  35. Emcure Pharmaceuticals NSE filing with press release 'Emcure Pharma Reduces Poviztra Starting Dose Price by 55%', 2026-04-02
  36. PubMed abstract, PMID 33567185
  37. PubMed abstract, PMID 35441470
  38. SuperKalam summary of the Indian Express, 2026-03-12
  39. Ministry of Health and Family Welfare press release via PIB, 2026-03-24

Medical Disclaimer

This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. The clinical trial results cited in this article reflect study averages from specific trial populations and may not predict individual outcomes. Drug availability, approved indications, and brand names vary by country and are subject to regulatory decisions by bodies such as the CDSCO in India, the FDA in the United States, and the EMA in Europe. Zelta does not endorse one medication over another. All treatment decisions are made by your prescribing clinician based on your individual health profile.

Ready to begin?

Find out if GLP-1 is right for you.

Take our free 2-minute assessment. A specialist doctor reviews every case.

Take free assessment